In 2011, Wolk et al. demonstrated an upregulation of the mRNA of IL-17A in the lesions of patients with HS and psoriasis, while the levels in control subjects and atopic dermatitis patients were not increased [27]. The gene discussed is IL17A; the disease is histiocytic sarcoma.